Les Laboratoires Servier SAS - Company Profile
Powered by 
All the sales intelligence you need on Les Laboratoires Servier SAS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Les Laboratoires Servier SAS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Les Laboratoires Servier SAS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Les Laboratoires Servier SAS Catalyst Calendar
Proactively evaluate Les Laboratoires Servier SAS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Les Laboratoires Servier SAS Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 27 Oct 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 07 Oct 2019 | Phase III Trial Completion | Adir Association; Servier Institute of International Research; Syneos Health Inc | SYNH | undisclosed micronised purified flavonoid fraction | Cardiovascular | Unspecified Cardiovascular Disorders | Clinical Trial Registry |
| 01 Oct 2019 | Phase III Trial Results | Sarah Cannon Research Institute LLC; Servier Institute of International Research | - | ivosidenib | Oncology | Bile Duct Cancer (Cholangiocarcinoma) | Company Press Release |
| 01 Oct 2019 | Phase II Trial Initiation | ADIR, a Servier Group Co; IQVIA Holdings Inc; Kyowa Kirin Co Ltd; Les Laboratoires Servier SAS; Servier Institute of International Research | 4151; IQV | pegaspargase | Oncology | Acute Lymphoblastic Lymphoma; Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia); Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer